Tvardi Therapeutics Inc. (TVRD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tvardi Therapeutics Inc.

    NASDAQ: TVRD · Real-Time Price · USD
    35.27
    -0.13 (-0.37%)
    At close: Sep 12, 2025, 12:53 PM

    Tvardi Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 7.14M 20.97M 41.87M 23.03M
    Cost of Revenue
    		 812K 6.43M 7.51M 1.55M
    Gross Profit
    		 6.33M 14.54M 34.35M 21.47M
    Operating Income
    		 -55.78M -18.66M -21.19M -89.08M
    Interest Income
    		 2.83M 1.32M 654K 603K
    Pretax Income
    		 -71.27M -17.35M -20.54M -88.44M
    Net Income
    		 -70.87M -17.35M -20.54M -88.44M
    Selling & General & Admin
    		 26.39M 2.8M 2.73M 27.98M
    Research & Development
    		 32.76M 15.87M 18.47M 82.58M
    Other Expenses
    		 2.96M n/a n/a n/a
    Operating Expenses
    		 62.11M 18.66M 21.19M 110.56M
    Interest Expense
    		 8.47M n/a 3K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 62.92M 18.66M 21.19M 112.11M
    Income Tax Expense
    		 -398K n/a n/a n/a
    Shares Outstanding (Basic)
    		 1.52M 9.36M 9.36M 1.41M
    Shares Outstanding (Diluted)
    		 1.52M 9.36M 9.36M 1.41M
    EPS (Basic)
    		 -46.59 -1.85 -2.2 -62.77
    EPS (Diluted)
    		 -46.59 -1.85 -2.2 -62.77
    EBITDA
    		 -62.6M -17.25M -20.45M -86.89M
    EBIT
    		 -62.79M -17.35M -20.54M -88.44M
    Depreciation & Amortization
    		 192K 95K 85K 1.55M

    Add to Watchlist